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Transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is a central 
regulator of cellular defense against oxidative stress and inflammation and is also 
involved in regulating liver regeneration. The aim of the study is to evaluate whether 
Nrf2 mediates hepatic repair response during cholestasis. Wild-type and Nrf2-null mice 
were subjected to bile duct ligation or sham operation. Various assessments were 
performed at 5, 10, 15, 25, and 40 days following surgery. Significant genotype-
dependent differences in liver injury, cell proliferation, and collagen deposition were not 
seen over the time course of the study, in line with several reports. However, Nrf2-null 
mice exhibited a more prominent network of septual tissue containing laminin and α-
fetal protein expressing cells  at 15 days after injury, suggesting a stronger repair 
response, than their wild-type litter mates. In the livers of both genotypes of mice, 
cytokeratin 19 (CK19), a marker of bipotent liver epithelial progenitors and immature 
billiary epithelial cells, were expressed in the epithelial cells of newly formed bile ducts 
and a population of hepatocytic-appearing cells in parenchyma. Notably, Nrf2-null mice 
showed higher hepatic protein expression of CK19 at 5 days following BDL, indicating 
earlier onset of the activation of CK19+ progenitor cells, than wild-types. CD133, a 
marker of liver progenitors, were found to be expressed by newly generated bile duct 
epithelial cells and a population of hepatocytic-appearing parenchymal cells in the livers 
of the two genotypes of mice. Hepatic CD133 protein expression was gradually 
elevated, paralleling continuous increase in the number of CD133+ hepatocytic-
appearing cells, as the cholestasis progressed. Remarkably, the lack of Nrf2 led to 
markedly higher magnitudes of the increases in hepatic CD133 protein level and in the 
number of CD133+ hepatocytic-appearing cells. Collectively, our data demonstrate that 
Nrf2 deficiency evokes higher activity of liver progenitor cells and thus stronger liver 
repair response. The findings indicate that Nrf2 is an important regulator of the activity 
of hepatic progenitor/stem cells during chronic liver injury.  
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